ETC
REGN icon

Exchange Traded Concepts’s Regeneron Pharmaceuticals REGN Stock Holding History

Exchange Traded Concepts’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.9M Sell
4,648
-1,158
-20% -$788K 0.01% 598
2026
Q1 		$4.49M Buy
5,806
+943
+19% +$722K 0.03% 425
2025
Q4 		$3.75M Sell
4,863
-446
-8% -$303K 0.03% 461
2025
Q3 		$2.99M Buy
5,309
+1,369
+35% +$774K 0.03% 487
2025
Q2 		$2.07M Buy
3,940
+588
+18% +$328K 0.03% 473
2025
Q1 		$2.13M Sell
3,352
-2,807
-46% -$1.93M 0.04% 367
2024
Q4 		$4.39M Buy
6,159
+2,139
+53% +$1.8M 0.09% 220
2024
Q3 		$4.23M Buy
4,020
+107
+3% +$119K 0.1% 191
2024
Q2 		$4.11M Buy
3,913
+764
+24% +$741K 0.1% 191
2024
Q1 		$3.03M Sell
3,149
-1,805
-36% -$1.72M 0.08% 227
2023
Q4 		$4.35M Buy
4,954
+1,221
+33% +$1.01M 0.12% 173
2023
Q3 		$3.07M Sell
3,733
-459
-11% -$361K 0.09% 179
2023
Q2 		$3.01M Sell
4,192
-200
-5% -$154K 0.07% 215
2023
Q1 		$3.61M Sell
4,392
-2,993
-41% -$2.26M 0.1% 149
2022
Q4 		$5.33M Buy
7,385
+3,266
+79% +$2.41M 0.15% 110
2022
Q3 		$2.84M Buy
4,119
+408
+11% +$257K 0.09% 123
2022
Q2 		$2.19M Sell
3,711
-1,501
-29% -$976K 0.06% 158
2022
Q1 		$3.64M Buy
5,212
+667
+15% +$422K 0.07% 149
2021
Q4 		$2.87M Sell
4,545
-547
-11% -$336K 0.06% 204
2021
Q3 		$3.08M Sell
5,092
-1,742
-25% -$1.08M 0.08% 181
2021
Q2 		$3.82M Sell
6,834
-66
-1% -$33.4K 0.12% 123
2021
Q1 		$3.27M Buy
6,900
+2,957
+75% +$1.44M 0.12% 115
2020
Q4 		$1.91M Buy
3,943
+2,343
+146% +$1.26M 0.09% 152
2020
Q3 		$896K Buy
1,600
+498
+45% +$302K 0.05% 178
2020
Q2 		$687K Buy
1,102
+804
+270% +$456K 0.11% 146
2020
Q1 		$146K Buy
298
+64
+27% +$26.4K 0.08% 225
2019
Q4 		$88K Buy
+234
New +$78.7K 0.02% 212

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Exchange Traded Concepts's REGN Position: Q2 2026 in Review

Exchange Traded Concepts reduced its Regeneron Pharmaceuticals (REGN) stake by 20% in Q2 2026, selling an estimated $788K and leaving 4,648 shares worth $2.9M. The position accounts for 0.01% of the portfolio, ranked #598.

Exchange Traded Concepts first reported a position in REGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.33M in Q4 2022. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Exchange Traded Concepts held 4,648 shares of Regeneron Pharmaceuticals worth $2.9M as of Q2 2026.
  • Exchange Traded Concepts sold 1,158 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $788K.
  • Regeneron Pharmaceuticals made up 0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #598 holding.
  • Exchange Traded Concepts first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • Exchange Traded Concepts's Regeneron Pharmaceuticals position peaked at $5.33M in Q4 2022.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.